Competition Coming for AbbVie’s Blockbuster

It’s among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats  Worldwide sales of Humira have totaled $200 billion in the last 20 years—just about the biggest haul in the history of prescription drugs. The bonanza was predicated on charging as much as $84,000 for ayear’s supply. But price relief is on the … Continued